Hemofília: vizsgálatok itt: Japán
12 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleEfanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- Where
- Hiroshima, Kawasaki, Saitama, Tokyo
- Életkor
- 12 év and over
- People
- 35 worldwide
- Run by
- Sanofi
See details and how to joinNCT06941870 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Kashihara-shi, Maebashi, Nagoya, Suginami-Ku
- Életkor
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - 3. fázisTaking peopleA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Hirakata-shi, Osaka, Maebashi-shi, Gunma, Nara, Niigata-shi, Niigata, Nishinomiya-shi, Hyogo, Tokyo
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00 - 3. fázisTaking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Azumino, Hiroshima, Kashihara, Lruma-gun, Nagoya, Saga, Saitama-shi
- Életkor
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - No phaseTaking peopleAn Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
- Where
- Many Locations
- Életkor
- 7 év to 12 év
- People
- 40 worldwide
- Run by
- Bayer
See details and how to joinNCT07088458 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Kashihara-shi, Shinjuku-ku
- Életkor
- 12 év and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - 3. fázisTaking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Azumino, Kashihara, Kobe, Saga, Saitama-Shi
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - 3. fázisTaking peopleSafety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Iruma-gun, Nagoya, Sapporo
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719 - 2. fázisTaking peopleA Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
- Where
- Bunkyo Ku, Osaka, Sapporo, Sendai
- Életkor
- 18 év to 79 év
- People
- 7
- Run by
- Kiminori Kimura, MD
See details and how to joinNCT07681089 - No phaseTaking peopleA Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
- Where
- Tokyo
- People
- 25
- Run by
- Takeda
See details and how to joinNCT06461533 - No phaseCsak meghívásosPost-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors
- Where
- Aomori, Fukuoka, Hokkaido, Kagoshima, Kanagawa, Kitakyusyu-shi, Fukuoka, Okinawa, Tokyo, Toshima City
- People
- 23
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06285071 - No phaseCsak meghívásosPost-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
- Where
- Chiba, Fukui, Fukushima, Hyōgo, Kanagawa, Kawagoe, Miyagi, Nagano, Nahano, Okinawa, Osaka, Saitama, Shimane, Shizuoka, Tokyo, Yamagata, Yokohama-shi, Kanagawa
- Életkor
- 12 év and over
- People
- 30
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06831734